EUDA Health (NASDAQ: EUDA) regains Nasdaq MVLS listing compliance

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

EUDA Health Holdings Limited reported that it has regained compliance with the Nasdaq Capital Market’s continued listing requirements related to market value. Nasdaq had previously notified EUDA on April 23, 2026 that its Market Value of Listed Securities was below the required $35 million for 32 consecutive business days under Nasdaq Listing Rule 5550(b)(2). A subsequent Nasdaq notice on May 28, 2026 confirmed that EUDA’s Market Value of Listed Securities was $35 million or greater for ten consecutive business days from May 13 to May 27, 2026, restoring the Company’s compliance with the MVLS standard.

Positive

Regained Nasdaq compliance: Nasdaq confirmed EUDA’s Market Value of Listed Securities was at least $35 million for ten consecutive business days, restoring compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market.

Negative

None.

Insights

EUDA has cured a Nasdaq market value deficiency and remains in compliance.

EUDA Health Holdings Limited confirmed it fell below Nasdaq’s required Market Value of Listed Securities of $35 million for 32 consecutive business days, triggering a deficiency notice under Listing Rule 5550(b)(2). This metric reflects the total market value of the company’s listed shares.

Nasdaq later confirmed EUDA’s market value was at least $35 million for ten straight business days from May 13–27, 2026, which restored compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market. The event is primarily regulatory and informational rather than operational.

The key dependency is EUDA’s ability to sustain market value at or above Nasdaq’s threshold. Future disclosures in company filings may provide more context on how the company manages capital markets visibility and trading dynamics that influence its listed market value.

Key Figures

MVLS requirement: $35 million Deficiency period length: 32 consecutive business days Compliance confirmation period: 10 consecutive business days +1 more

4 metrics

MVLS requirement $35 million Minimum Market Value of Listed Securities under Nasdaq Listing Rule 5550(b)(2)

Deficiency period length 32 consecutive business days Period during which EUDA’s MVLS was below $35 million before April 23, 2026 notice

Compliance confirmation period 10 consecutive business days MVLS at or above $35 million from May 13 to May 27, 2026

Compliance confirmation date May 28, 2026 Date Nasdaq notified EUDA it had regained MVLS compliance

Key Terms

Market Value of Listed Securities, Nasdaq Listing Rule 5550(b)(2), continued listing, foreign private issuer

4 terms

Market Value of Listed Securities financial

"the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million"

The market value of listed securities is the total worth of stocks, bonds and other tradable instruments quoted on an exchange, measured using the prices investors are willing to pay right now. It’s calculated by multiplying each security’s current market price by the number of units outstanding and adding those amounts together, like totaling the value of every item in a store at today’s prices. Investors watch this because it shows the size, liquidity and overall health of the market or a company’s publicly traded portion, and it influences index weights, fund allocations and perceived risk.

Nasdaq Listing Rule 5550(b)(2) regulatory

"as required by the Nasdaq Listing Rule 5550(b)(2)"

continued listing regulatory

"regained compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market"

When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

06/01/2026 - 07:30 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-40678

EUDA Health Holdings Limited

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: +65 6327 1110

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

On April 23, 2026, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million over the last 32 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).

On May 28, 2026, the Company received a written notice from Nasdaq stating that the Company’s Market Value of Listed Securities has been $35 million or greater for ten consecutive business days from May 13 to May 27, 2026, and therefore the Company has regained compliance with the MVLS requirement for continued listing on the Nasdaq Capital Market.

Exhibits

99.1

Press release dated June 1, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: June 1, 2026

	EUDA Health Holdings Limited

	By:	/s/ Alfred Lim
	Name:	Alfred Lim
	Title:	Chief Executive Officer

Exhibit 99.1

EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

Singapore, June 1, 2026 (Globe Newswire) - EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice (the “MVLS Notice”) from Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) on April 23, 2026, indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities (“MVLS”) of $35 million over the last 32 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).

For investor and media inquiries, please contact:

Christensen Advisory

Christian Arnell

Phone: +852 2117 0861

Email: christian.arnell@christensencomms.com

Source: View Original Filing on SEC EDGAR

FAQ

What Nasdaq listing issue did EUDA (EUDA) face regarding market value?

EUDA received a Nasdaq notice on April 23, 2026 stating it failed to maintain a Minimum Market Value of Listed Securities of $35 million for 32 consecutive business days, as required by Nasdaq Listing Rule 5550(b)(2).

How did EUDA (EUDA) regain compliance with Nasdaq MVLS rules?

Nasdaq notified EUDA on May 28, 2026 that its Market Value of Listed Securities was $35 million or greater for ten consecutive business days from May 13 to May 27, 2026, restoring compliance with MVLS requirements.

What is the Nasdaq Market Value of Listed Securities requirement for EUDA (EUDA)?

Nasdaq Listing Rule 5550(b)(2) requires EUDA to maintain a Minimum Market Value of Listed Securities of $35 million. Falling below this threshold for a defined period can trigger a deficiency notice from Nasdaq.

What does EUDA’s MVLS compliance mean for its Nasdaq Capital Market listing?

Regaining MVLS compliance means Nasdaq confirmed EUDA’s listed share value met the $35 million threshold for ten consecutive business days, so it currently satisfies this continued listing standard on the Nasdaq Capital Market.

When were EUDA’s MVLS deficiency and recovery periods measured by Nasdaq?

The deficiency notice referenced the prior 32 consecutive business days before April 23, 2026. Compliance was regained after EUDA’s Market Value of Listed Securities was at least $35 million from May 13 to May 27, 2026.

Filing Exhibits & Attachments

2 documents